摘要
目的通过临床药师干预重点监控药品的合理应用,促进临床合理用药。方法通过临床药学管理系统(PASS PharmAssist)调取南通市第一人民医院2019年10月至2020年6月重点监控药品的使用数据并筛选在此期间使用重点监控药品的出院患者,对干预前(2019年第四季度)与干预后(2020年第一季度、第二季度)重点监控药品金额、重点监控药品金额占药品总金额的比例以及不合理使用率进行分析。结果临床药师干预后重点监控药品金额较干预前下降33.23%,重点监控药品金额占药品总金额比例下降34.77%,不合理使用率49.7%下降至30.7%。结论临床药师干预效果良好,提高重点监控药品的用药合理性,同时减轻患者经济负担。
Objective To monitor the rational use of key monitored drugs by clinical pharmacists'intervention and promote the clinical rational use of drugs.Methods The use data of key monitored drugs from October 2019 to June 2020 in Nantong First People's Hospital were retrieved through the Prescription Automatic Screening System of Pharmassist(PASS PharmAssist)and the discharged patients using the key monitored drugs during this period were screened.The consumption sum of key monitored drugs,the ratio of the consumption sum of key monitored drugs to the total consumption sum of drugs,and the unreasonable use rate before the intervention(the fourth quarter of 2019)and after the intervention(the first and second quarters of 2020)were analyzed.Results After the intervention of clinical pharmacists,the consumption sum of key monitored drugs decreased by 33.23%compared with that before the intervention.The consumption sum of key monitored drugs in the total consumption sum of drugs decreased by 34.77%,and the unreasonable use rate decreased from 49.7%to 30.7%.Conclusion The effect of clinical pharmacist intervention is good,which improves the rationality of key monitored drug use and reduces the economic burden of patients.
作者
顾小丽
柳小亚
陈霞
GU Xiaoli;LIU Xiaoya;CHEN Xia(Department of Pharmacy,Nantong First People's Hospital,Jiangsu,Nantong 226001,China)
出处
《中国医药科学》
2021年第12期127-130,161,共5页
China Medicine And Pharmacy
基金
江苏省药学会-奥赛康临床药学基金科研项目(A201928)
江苏省南通市市级科技计划项目(JCZ20139)。
关键词
临床药师
干预
重点监控
合理用药
Clinical pharmacist
Intervention
Key monitoring
Rational drug use
